𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical Dosage Determination of a New Aromatase Inhibitor, Anastrozole, in Postmenopausal Japanese Women with Advanced Breast Cancer

✍ Scribed by Yasuo Nomura, Hiroki Koyama, Yasuo Ohashi, Hiroshi Watanabe

Book ID
119929594
Publisher
Springer International Publishing AG
Year
2000
Tongue
English
Weight
249 KB
Volume
20
Category
Article
ISSN
1179-1918

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Use of aromatase inhibitors in postmenop
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer
✍ Roseman, Barry J.; Buzdar, Aman U.; Singletary, S. Eva πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 39 KB πŸ‘ 2 views

Surgeons have been involved in the management of metastatic breast cancer since the technique of ovarian ablation was introduced in 1896. However, as newer hormonal and chemotherapeutic regimens were developed, drug therapy gradually replaced surgery as the preferred treatment for metastatic breast

Summary of aromatase inhibitor clinical
Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer
✍ Aman U. Buzdar; R. Charles Coombes; Paul E. Goss; Eric P. Winer πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 115 KB

Five years of adjuvant therapy with tamoxifen was considered the gold-standard treatment for postmenopausal women with estrogen receptor-positive breast cancer for many years. Data from a core group of clinical trials investigating the safety and efficacy of aromatase inhibitors (AIs) have challenge